• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    agilon health Announces New Physician Partnerships for 2025

    5/7/24 3:55:00 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care
    Get the next $AGL alert in real time by email

    agilon's latest long-term partnerships with leading multi-specialty and independent primary care practices will expand the delivery of value-based care to more seniors and new communities

    More than 3,000 primary care doctors are now part of agilon's growing Physician Network

    agilon health (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has formed long-term partnerships with five new physician practices across the U.S. to enable their transition to a full-risk, value-based care model. Recognized leaders in their respective communities, the new partners include Graves Gilbert Clinic in Kentucky, Mankato Clinic in Minnesota, Springfield Clinic in Illinois, and Twin Cities Network in Minnesota, as well as an independent, multi-specialty practice in North Carolina to be named at a later date.

    With these new partnerships, agilon's Physician Network will grow to include over 3,000 primary care physicians who are delivering value-based care to more than 700,000 senior patients in 30+ communities. Additionally, agilon will enter the state of Illinois for the first time and expand its existing broad footprint in Kentucky, Minnesota and North Carolina.

    "More leading physician practices want to join agilon health's Physician Network and platform to be part of the movement toward value-based care," said Steve Sell, chief executive officer, agilon health. "Our new partnerships with these five leading physician practices demonstrate the power of our growing Network, especially in communities where we operate today like Kentucky, Minnesota and North Carolina. Each of our new partners has built a strong reputation in their local community and we look forward to enriching the quality of care to their senior patients."

    By partnering with agilon, physician practices make a joint commitment to transform health care delivery by shifting to a value-based Total Care Model for their Medicare patients that improves outcomes and lowers cost. Established in 2016, agilon has deep expertise in full-risk, value-based care for Medicare Advantage and Fee-for-Service innovation models. Today, more than 30 physician groups and health systems are in long-term partnerships with agilon and have transitioned to full-risk for their Medicare patients through agilon's technology-enabled platform.

    "We are excited about this partnership with agilon health," stated Jerry Roy, MD, Chair of the Graves Gilbert Clinic and 2025 agilon health partner. "Having a value-based care partner of this magnitude will be a significant lift for patient care and understanding how to help manage quality, access and value in our health care environment. This is a real game changer for primary care."

    About the new partners

    Graves Gilbert Clinic was founded in 1937 and is South Central Kentucky's largest physician-owned medical group. Graves Gilbert Clinic has 200+ providers; over one million patients visit their clinics annually. Graves Gilbert Clinic has providers in 30 specialties and 25+ locations throughout South Central Kentucky.

    Mankato Clinic was founded in 1916 by five area physicians who believed that a comprehensive, multi-specialty group practice offered the best means of providing quality health care to the residents of southern Minnesota. Mankato Clinic has grown to over 180 physicians and practitioners and employs nearly 900 people. It is the largest physician-owned and led multi-specialty healthcare group in the state of Minnesota.

    Springfield Clinic has been dedicated to delivering the highest quality primary and specialty care to patients in central Illinois since 1939. A community-based organization, Springfield Clinic has more than 650 physicians and advanced practitioners delivering care in more than 80 medical specialties and sub-specialties. The practice's physicians, nurses and employees live, work and take great pride in the more than 20 counties they serve in central Illinois.

    The Twin Cities Network is comprised of three independent practices located in the Twin Cities area of Minnesota: Edina Sports & Family Medicine, France Avenue Family Physicians and Northwest Family Clinics. Edina Sports & Family Medicine provides complete family practice services plus additional experts in sports medicine and holistic medicine to meet the changing needs of today's family. France Avenue Family Physicians is an independent private practice specializing in family practice, with nine practitioners dedicated to providing excellence in personalized, compassionate, high-tech care that is consistent and choice-conscious for patients. Northwest Family Clinics, a physician-owned group of specialists in family medicine for nearly 70 years, provides comprehensive, coordinated and high-quality medical care to patients in all stages of life, with 20+ providers spread across three locations.

    About agilon health

    agilon health is the trusted partner empowering physicians to transform health care in our communities. Through our partnerships and purpose-built platform, agilon is accelerating at scale how physician groups and health systems transition to a value-based Total Care Model for their senior patients. agilon provides the technology, people, capital, process and access to a peer network of 3,000+ PCPs that allow physician groups to maintain their independence and focus on the total health of their most vulnerable patients. Together, agilon and its physician partners are creating the health care system we need – one built on the value of care, not the volume of fees. The result: healthier communities and empowered doctors. agilon is the trusted partner in 30+ diverse communities and is here to help more of our nation's leading physician groups and health systems have a sustained, thriving future. For more information about agilon health, visit www.agilonhealth.com and connect with us on LinkedIn, Instagram and YouTube.

    Forward Looking Statements

    Statements in this release that are not historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among other things, statements regarding our and our officers' intent, belief or expectation as identified by the use of words such as "may," "will," "project," "expect," "believe," "intend," "anticipate," "seek," "target," "forecast," "plan," "potential," "estimate," "could," "would," "should," and other comparable and derivative terms or the negatives of such words. Examples of forward-looking statements in this release include, among other things, statements regarding our ability to grow and continue to expand our business, the expansion of our operations, the growth of our physician network and business, and number of Medicare Advantage members on our platform. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: our ability to expand into and develop successful new geographies, physician partners and health plan payors; our ability to execute upon our growth initiatives and operating strategies, and our ability to grow our Medicare Advantage members, and additional risks related to other factors discussed under "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023. Except as required by law, we do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240507824390/en/

    Get the next $AGL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGL

    DatePrice TargetRatingAnalyst
    8/20/2025$1.40Outperform → Mkt Perform
    Bernstein
    8/6/2025$1.00Buy → Neutral
    Citigroup
    4/25/2025$5.00Neutral → Buy
    Citigroup
    4/8/2025$8.50Mkt Perform → Outperform
    Bernstein
    1/10/2025$1.75 → $2.25Sell → Neutral
    Citigroup
    1/10/2025Hold
    Needham
    12/16/2024Neutral
    Macquarie
    12/11/2024$2.50Mkt Perform
    Bernstein
    More analyst ratings

    $AGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Agilon Health downgraded by Bernstein with a new price target

    Bernstein downgraded Agilon Health from Outperform to Mkt Perform and set a new price target of $1.40

    8/20/25 8:21:47 AM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    Agilon Health downgraded by Citigroup with a new price target

    Citigroup downgraded Agilon Health from Buy to Neutral and set a new price target of $1.00

    8/6/25 7:57:52 AM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    Agilon Health upgraded by Citigroup with a new price target

    Citigroup upgraded Agilon Health from Neutral to Buy and set a new price target of $5.00

    4/25/25 8:23:09 AM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $AGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    agilon health Sets Date to Report Third Quarter 2025 Financial Results

    agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the third quarter 2025 after market close on Tuesday, November 4, 2025 and host a conference call at 4:30 p.m. ET to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 291396. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of the call will be availabl

    10/6/25 4:12:00 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    agilon health to Participate in the 2025 Jefferies Healthcare Services Conference

    agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the 2025 Jefferies Healthcare Services Conference on Tuesday, September 30 at 8:45am ET. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the "Events & Presentations" section of agilon health's investor relations website at https://investors.agilonhealth.com. Replays will be available for on-demand listening shortly after the completion of the presentation. About agilon health agilon health is the trusted partner empowering physici

    9/16/25 4:05:00 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    agilon health Announces Leadership Transition

    Steven Sell steps down as President, Chief Executive Officer, and Board Director Ronald A. Williams, co-founder, Board Chairman, and healthcare industry veteran, appointed Executive Chairman Board establishes an Office of the Chairman and initiates search for permanent CEO Company reports second quarter 2025 earnings and withdraws full year 2025 guidance agilon health (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Steven Sell has stepped down as President, CEO, and a Director of the Board. Ronald A. Williams, the Company's co-founder and Board Chairman since 2017, has been appointed Executive Chairman. Williams

    8/4/25 4:10:00 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $AGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Gertsch Timothy covered exercise/tax liability with 406 shares, decreasing direct ownership by 0.35% to 114,752 units (SEC Form 4)

    4 - agilon health, inc. (0001831097) (Issuer)

    8/19/25 5:39:24 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    Chief Legal Officer Zamore Denise covered exercise/tax liability with 915 shares, decreasing direct ownership by 0.21% to 443,125 units (SEC Form 4)

    4 - agilon health, inc. (0001831097) (Issuer)

    8/5/25 5:10:48 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    Chief Financial Officer Schwaneke Jeffrey A. covered exercise/tax liability with 46,099 shares, decreasing direct ownership by 4% to 1,075,122 units (SEC Form 4)

    4 - agilon health, inc. (0001831097) (Issuer)

    7/3/25 4:08:23 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $AGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Schwaneke Jeffrey A. bought $250,206 worth of shares (22,300 units at $11.22) and was granted 428,922 shares, increasing direct ownership by 61% to 1,130,552 units (SEC Form 4)

    4/A - agilon health, inc. (0001831097) (Issuer)

    4/3/25 7:40:25 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    CEO & President Sell Steven covered exercise/tax liability with 15,563 shares and bought 42,426 shares, increasing direct ownership by 8% to 355,310 units (SEC Form 4)

    4 - agilon health, inc. (0001831097) (Issuer)

    3/18/25 6:42:37 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    Chief Markets Officer Shaker Benjamin bought 11,786 shares and covered exercise/tax liability with 4,143 shares, increasing direct ownership by 2% to 457,058 units (SEC Form 4)

    4 - agilon health, inc. (0001831097) (Issuer)

    3/18/25 6:41:48 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $AGL
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.

    SCHEDULE 13G/A - agilon health, inc. (0001831097) (Subject)

    9/5/25 5:41:23 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SCHEDULE 13G filed by agilon health inc.

    SCHEDULE 13G - agilon health, inc. (0001831097) (Subject)

    8/29/25 11:00:27 AM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.

    SCHEDULE 13G/A - agilon health, inc. (0001831097) (Subject)

    8/13/25 12:56:59 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $AGL
    Financials

    Live finance-specific insights

    View All

    agilon health Sets Date to Report Third Quarter 2025 Financial Results

    agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the third quarter 2025 after market close on Tuesday, November 4, 2025 and host a conference call at 4:30 p.m. ET to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 291396. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of the call will be availabl

    10/6/25 4:12:00 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    agilon health Sets Date to Report Second Quarter 2025 Financial Results

    agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2025 after the market closes on Tuesday, August 5, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 938716. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of t

    7/22/25 4:05:00 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    agilon health Sets Date to Report First Quarter 2025 Financial Results

    agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2025 after the market closes on Tuesday, May 6, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 095319. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of the ca

    3/25/25 4:05:00 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $AGL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by agilon health inc.

    SC 13G/A - agilon health, inc. (0001831097) (Subject)

    11/13/24 12:49:26 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by agilon health inc.

    SC 13G/A - agilon health, inc. (0001831097) (Subject)

    11/8/24 10:52:39 AM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by agilon health inc.

    SC 13G/A - agilon health, inc. (0001831097) (Subject)

    11/6/24 4:47:14 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $AGL
    Leadership Updates

    Live Leadership Updates

    View All

    agilon health Announces Leadership Transition

    Steven Sell steps down as President, Chief Executive Officer, and Board Director Ronald A. Williams, co-founder, Board Chairman, and healthcare industry veteran, appointed Executive Chairman Board establishes an Office of the Chairman and initiates search for permanent CEO Company reports second quarter 2025 earnings and withdraws full year 2025 guidance agilon health (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Steven Sell has stepped down as President, CEO, and a Director of the Board. Ronald A. Williams, the Company's co-founder and Board Chairman since 2017, has been appointed Executive Chairman. Williams

    8/4/25 4:10:00 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer

    Dr. Rao to Continue to Lead Clinical Strategy and Drive Physician Network Performance Alongside agilon's Chief Clinical Officer Kevin Spencer, M.D. agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon's interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company. Prior to joining agilon in 2022, Dr. Rao held several roles in value-based care, including nearly a d

    7/10/24 8:00:00 AM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    agilon health Names Jeff Schwaneke New Chief Financial Officer

    agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon's board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon's Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Schwaneke succeeds Timothy Bensley, who announced his retirement from agilon in early 2024. Bensley has agreed to stay on through a transition period. Schwaneke was most recently executive vice president, Health Care Enterprises,

    6/5/24 8:00:00 AM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care